Although depletion of CD4+ T cells suppressed overall tumor volume, possibly through depletion of regulatory T cells (Tregs) (Kim et al., 2021), CD4 depletion abrogated antitumor activity of CTA (Fig. 3 C). This evidence concerns the gene CD4 and neoplasm.